Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis

被引：3
|
作者：
Aravindan, Ananthakrishnapuram [1 ]
Yong, Jim [2 ]
Killingsworth, Murray [2 ]
Suranyi, Michael [1 ]
Wong, Jeffrey [1 ]
机构：
[1] Liverpool Hosp, Dept Nephrol, Frederick, MD 2170 USA
[2] Liverpool Hosp, Dept Anat Pathol, Liverpool, NSW 2170, Australia
来源：
CLINICAL KIDNEY JOURNAL | 2010年 / 3卷 / 02期
关键词：
interferon beta; minimal change disease; nephrotic syndrome; relapsing remitting multiple sclerosis;
D O I：
10.1093/ndtplus/sfp162
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Interferon beta is widely used for the treatment of relapsing and remitting multiple sclerosis. Renal side effects including nephrotic syndrome have been increasingly described with interferon beta treatment. We describe an illustrative case of a patient who developed severe nephrotic syndrome due to minimal change disease in association with interferon beta therapy and showed partial remission following cessation of interferon beta and treatment with corticosteroids.
引用
收藏
页码：132 / 134
页数：3
相关论文
共 50 条
  • [1] Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
    Drulovic, Jelena
    Kostic, Jelena
    Mesaros, Sarlota
    Basuroski, Irena Dujmovic
    Stojsavljevic, Nebojsa
    Kisic-Tepavcevic, Darija
    Pekmezovic, Tatjana
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S65 - S69
  • [2] The role of endogenous interferon-beta in the pathogenesis of relapsing remitting multiple sclerosis
    Zhang, X.
    Tao, Y.
    Markovic-Plese, S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 330 - 330
  • [3] Neutralising Antibodies to Interferon-beta Therapy in Chinese Patients with Relapsing and Remitting Multiple Sclerosis.
    Ip, W. K.
    Lau, A. Y. L.
    Zhang, S.
    Au, C. C. K.
    Wong, W.
    Lau, K. K.
    Li, P.
    Chan, E. Y. T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 416 - 417
  • [4] Response to interferon-beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (03) : 281 - 286
  • [5] Long Term Effect of Interferon-Beta on Disease Severity in Relapsing-Remitting Multiple Sclerosis Patients
    Patrucco, Liliana B.
    Rojas, Juan I.
    Cristiano, Edgardo
    [J]. NEUROLOGY, 2009, 72 (11) : A235 - A235
  • [6] Long term effect of interferon-beta on disease severity in relapsing-remitting multiple sclerosis patients
    Patrucco, Liliana
    Ignacio Rojas, Juan
    Cristiano, Edgardo
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 (09) : 529 - 532
  • [7] A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis
    Goodin, Douglas S.
    [J]. NEUROLOGY, 2006, 67 (07) : 1313 - 1313
  • [8] Side effects of interferon-beta 1a in relapsing-remitting multiple sclerosis
    Lotfi, J
    Adibnejad, S
    Beheshtian, A
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 64 - 64
  • [9] A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis
    Koch-Henriksen, N
    Sorensen, PS
    Christensen, T
    Frederiksen, J
    Ravnborg, M
    Jensen, K
    Heltberg, A
    Kristensen, O
    Stenager, E
    Petersen, T
    Hansen, T
    [J]. NEUROLOGY, 2006, 66 (07) : 1056 - 1060
  • [10] The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis
    Koch-Henriksen, N
    Sorensen, PS
    [J]. MULTIPLE SCLEROSIS, 2000, 6 (03): : 172 - 175
12345